Impaired Coronary Microvascular Dilation Correlates with Enhanced Vascular Smooth Muscle MLC Phosphorylation in Diabetes

Overview

Journal Microcirculation

Specialties Biology
Cardiology & Vascular Diseases

Date 2009 Jan 20

PMID 19152178

Citations 12

Authors

Richard T Clements

Neel R Sodha

Jun Feng

Munir Boodhwani

Yuhong Liu

Shigetoshi Mieno

Kamal R Khabbaz

Cesario Bianchi

Frank W Sellke

Affiliations

Soon will be listed here.

Abstract

Objective: Impaired endothelium-independent vasodilation is a known consequence of types 1 and 2 diabetes, and the mechanism of impaired vasodilation is not well understood. The following study investigated the effects of types 1 and 2 diabetes in endothelial-independent vasodilation associated with coronary vascular smooth muscle (VSM) relaxation and contractile signaling mechanisms.

Materials And Methods: Type 1 diabetes was induced in Yucatan miniswine via alloxan injection and treated with or without insulin (DM and IDM). Nondiabetic swine served as controls (ND). Expression and/or phosphorylation of determinants of VSM relaxation and contraction signaling were examined in coronary arteries and microvessels. Coronary microvessel relaxation was assessed by using sodium nitroprusside (SNP). In addition, SNP-induced vasodilation and myosin light-chain (MLC) phosphorylation was determined in coronary microvessels isolated from ND and type 2 diabetic human atrial appendage.

Results: Diabetic impairment in SNP-induced relaxation was completely normalized by insulin. Soluble guanylate cyclase (sGC) VSM expression decreased in both DM and IDM groups and did not correlate with vasorelaxation. Phosphorylation of MLC and myosin phosphatase increased in the DM group and MLC phosphorylation strongly correlated with impaired VSM relaxation (r=0.670, P<0.01). Coronary microvessels from type 2 diabetic human patients exhibited similarly impaired vasodilation and enhanced VSM MLC phosphorylation.

Conclusions: Impaired vasodilation in type 1 diabetes correlates with enhanced VSM MLC phosphorylation. In addition, enhanced VSM MLC phosphorylation is associated with impaired vasodilation in type 2 diabetes in humans.

Citing Articles

Mechanisms and clinical implications of endothelium-dependent vasomotor dysfunction in coronary microvasculature.

Sabe S, Feng J, Sellke F, Abid M Am J Physiol Heart Circ Physiol. 2022; 322(5):H819-H841.

PMID: 35333122 PMC: 9018047. DOI: 10.1152/ajpheart.00603.2021.

Myocardial Blood Flow Control by Oxygen Sensing Vascular Kvβ Proteins.

Ohanyan V, Raph S, Dwenger M, Hu X, Pucci T, Mack G Circ Res. 2021; 128(6):738-751.

PMID: 33499656 PMC: 8486354. DOI: 10.1161/CIRCRESAHA.120.317715.

The Altered Signaling on EFS-Induced Colon Contractility in Diabetic Rats.

Thein W, Po W, Kim D, Sohn U Biomol Ther (Seoul). 2020; 28(4):328-336.

PMID: 32126734 PMC: 7327146. DOI: 10.4062/biomolther.2019.181.

Comparison of cerebral and cutaneous microvascular dysfunction with the development of type 1 diabetes.

Feng W, Liu S, Zhang C, Xia Q, Yu T, Zhu D Theranostics. 2019; 9(20):5854-5868.

PMID: 31534524 PMC: 6735377. DOI: 10.7150/thno.33738.

Ethanol promotes arteriogenesis and restores perfusion to chronically ischemic myocardium.

Lassaletta A, Elmadhun N, Liu Y, Feng J, Burgess T, Karlson N Circulation. 2013; 128(11 Suppl 1):S136-43.

PMID: 24030397 PMC: 3983870. DOI: 10.1161/CIRCULATIONAHA.112.000207.

References

Lee J, Ragolia L . AKT phosphorylation is essential for insulin-induced relaxation of rat vascular smooth muscle cells. Am J Physiol Cell Physiol. 2006; 291(6):C1355-65. PMC: 1636679. DOI: 10.1152/ajpcell.00125.2006. View

Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T . Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem. 1996; 271(34):20246-9. DOI: 10.1074/jbc.271.34.20246. View

Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M . Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science. 1996; 273(5272):245-8. DOI: 10.1126/science.273.5272.245. View

Munzel T, Daiber A, Ullrich V, Mulsch A . Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler Thromb Vasc Biol. 2005; 25(8):1551-7. DOI: 10.1161/01.ATV.0000168896.64927.bb. View

Browner N, Dey N, Bloch K, Lincoln T . Regulation of cGMP-dependent protein kinase expression by soluble guanylyl cyclase in vascular smooth muscle cells. J Biol Chem. 2004; 279(45):46631-6. DOI: 10.1074/jbc.M408518200. View

Di Carli M, Janisse J, Grunberger G, Ager J . Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol. 2003; 41(8):1387-93. DOI: 10.1016/s0735-1097(03)00166-9. View

Noda M, Moriishi K, Kato T, Okuda T, Kurokawa K, Takuwa Y . Involvement of rho in GTP gamma S-induced enhancement of phosphorylation of 20 kDa myosin light chain in vascular smooth muscle cells: inhibition of phosphatase activity. FEBS Lett. 1995; 367(3):246-50. DOI: 10.1016/0014-5793(95)00573-r. View

Goodfellow J . Microvascular heart disease in diabetes mellitus. Diabetologia. 1997; 40 Suppl 2:S130-3. DOI: 10.1007/s001250051428. View

Hsueh W, Quinones M . Role of endothelial dysfunction in insulin resistance. Am J Cardiol. 2003; 92(4A):10J-17J. DOI: 10.1016/s0002-9149(03)00611-8. View

10.

Chang S, Hypolite J, DiSanto M, Changolkar A, Wein A, Chacko S . Increased basal phosphorylation of detrusor smooth muscle myosin in alloxan-induced diabetic rabbit is mediated by upregulation of Rho-kinase beta and CPI-17. Am J Physiol Renal Physiol. 2005; 290(3):F650-6. DOI: 10.1152/ajprenal.00235.2005. View

11.

Brooks B, McLennan S, Twigg S, Yue D . Detection and characterisation of microcirculatory abnormalities in the skin of diabetic patients with microvascular complications. Diab Vasc Dis Res. 2008; 5(1):30-5. DOI: 10.3132/dvdr.2008.006. View

12.

Sanz E, Fernandez N, Monge L, Martinez M, Climent B, Dieguez G . Effects of diabetes on the vascular response to nitric oxide and constrictor prostanoids: gender and regional differences. Life Sci. 2003; 72(13):1537-47. DOI: 10.1016/s0024-3205(02)02444-x. View

13.

Miura H, Wachtel R, Loberiza Jr F, Saito T, Miura M, Nicolosi A . Diabetes mellitus impairs vasodilation to hypoxia in human coronary arterioles: reduced activity of ATP-sensitive potassium channels. Circ Res. 2003; 92(2):151-8. DOI: 10.1161/01.res.0000052671.53256.49. View

14.

Bender S, Klabunde R . Altered role of smooth muscle endothelin receptors in coronary endothelin-1 and alpha1-adrenoceptor-mediated vasoconstriction in Type 2 diabetes. Am J Physiol Heart Circ Physiol. 2007; 293(4):H2281-8. DOI: 10.1152/ajpheart.00566.2007. View

15.

Koltai M, Hadhazy P, Posa I, Kocsis E, Winkler G, Rosen P . Characteristics of coronary endothelial dysfunction in experimental diabetes. Cardiovasc Res. 1997; 34(1):157-63. DOI: 10.1016/s0008-6363(97)00050-3. View

16.

Sundell J, Laine H, Nuutila P, Ronnemaa T, Luotolahti M, Raitakari O . The effects of insulin and short-term hyperglycaemia on myocardial blood flow in young men with uncomplicated Type I diabetes. Diabetologia. 2002; 45(6):775-82. DOI: 10.1007/s00125-002-0819-4. View

17.

Heitzer T, Krohn K, Albers S, Meinertz T . Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus. Diabetologia. 2000; 43(11):1435-8. DOI: 10.1007/s001250051551. View

18.

Su X, Changolkar A, Chacko S, Moreland R . Diabetes decreases rabbit bladder smooth muscle contraction while increasing levels of myosin light chain phosphorylation. Am J Physiol Renal Physiol. 2004; 287(4):F690-9. DOI: 10.1152/ajprenal.00027.2004. View

19.

Schachinger V, Britten M, Zeiher A . Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000; 101(16):1899-906. DOI: 10.1161/01.cir.101.16.1899. View

20.

Xie Z, Su W, Guo Z, Pang H, Post S, Gong M . Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells. Cardiovasc Res. 2005; 69(2):491-501. DOI: 10.1016/j.cardiores.2005.11.002. View